Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial
Top Cited Papers
- 1 February 2003
- journal article
- clinical trial
- Published by Elsevier BV in The Lancet
- Vol. 361 (9356), 449-456
- https://doi.org/10.1016/s0140-6736(03)12459-2
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- Scientific rationale for inhaled combination therapy with long-acting β2-agonists and corticosteroidsEuropean Respiratory Journal, 2002
- Inhaled Formoterol Dry Powder Versus Ipratropium Bromide in Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2001
- Alternative Mechanisms for Long-Acting β2-Adrenergic Agonists in COPDSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2001
- An empirical comparison of the St George's Respiratory Questionnaire (SGRQ) and the Chronic Respiratory Disease Questionnaire (CRQ) in a clinical trial settingThorax, 1999
- Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary diseaseThorax, 1999
- Long-Term Treatment with Inhaled Budesonide in Persons with Mild Chronic Obstructive Pulmonary Disease Who Continue SmokingThe New England Journal of Medicine, 1999
- Efficacy, tolerability, and effects on quality of life of inhaled salmeterol and oral theophylline in patients with mild-to-moderate chronic obstructive pulmonary diseaseClinical Therapeutics, 1998
- Quality of life and hospital re-admission in patients with chronic obstructive pulmonary diseaseThorax, 1997
- Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task ForceEuropean Respiratory Journal, 1995
- Reliability and validity of the chronic respiratory questionnaire (CRQ).Thorax, 1994